M. Arlotti

1.0k total citations
20 papers, 567 citations indexed

About

M. Arlotti is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, M. Arlotti has authored 20 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in M. Arlotti's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (8 papers). M. Arlotti is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (8 papers). M. Arlotti collaborates with scholars based in Italy, United Kingdom and United States. M. Arlotti's co-authors include Alessandro Cozzi Lepri, Antonella d’Arminio Monforte, Giuseppe Ippolito, Mauro Moroni, Mauro Giordano, Eduardo Arathoon, Joseph G. Jemsek, Vadim Pokrovskiy, Alexandra Thiry and G. Magnani and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Arlotti

18 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Arlotti Italy	10	378	231	163	146	71	20	567
Orasri Wittawatmongkol Thailand	13	311 0.8×	92 0.4×	181 1.1×	89 0.6×	66 0.9×	45	556
Barbara Rossetti Italy	16	498 1.3×	230 1.0×	238 1.5×	93 0.6×	22 0.3×	63	769
Evangelo Boumis Italy	14	276 0.7×	139 0.6×	244 1.5×	78 0.5×	10 0.1×	35	571
Marcos Tadeu Nolasco da Silva Brazil	13	141 0.4×	50 0.2×	154 0.9×	63 0.4×	29 0.4×	32	366
Thanomsak Anekthananon Thailand	14	546 1.4×	193 0.8×	409 2.5×	79 0.5×	8 0.1×	29	757
Faïza Ajana France	15	489 1.3×	367 1.6×	298 1.8×	168 1.2×	26 0.4×	44	796
Brian A. Reikie Canada	9	155 0.4×	80 0.3×	161 1.0×	49 0.3×	17 0.2×	13	465
Caroline Chapuis‐Taillard Switzerland	7	124 0.3×	39 0.2×	126 0.8×	80 0.5×	50 0.7×	10	310
Casper Roed Denmark	17	241 0.6×	51 0.2×	216 1.3×	123 0.8×	94 1.3×	32	710
Ruxandra Câlin France	14	253 0.7×	211 0.9×	130 0.8×	46 0.3×	12 0.2×	35	433

Countries citing papers authored by M. Arlotti

Since Specialization

Citations

This map shows the geographic impact of M. Arlotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arlotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arlotti more than expected).

Fields of papers citing papers by M. Arlotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arlotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arlotti. The network helps show where M. Arlotti may publish in the future.

Co-authorship network of co-authors of M. Arlotti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arlotti. A scholar is included among the top collaborators of M. Arlotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arlotti. M. Arlotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Piselli, Pierluca, Claudia Cimaglia, M. Arlotti, et al.. (2022). The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac. Clinical Microbiology and Infection. 28(12). 1636–1643. 5 indexed citations

2.

Arlotti, M., et al.. (2020). Politiche di LTC e disuguaglianze nel caso italiano: evidenze empiriche e ipotesi di riforma. Università Politecnica delle Marche (Università Politecnica delle Marche). 1. 125–148. 4 indexed citations

3.

Monti, Franco, Marco Rosetti, P. Bassi, et al.. (2017). Appropriatezza nel conteggio citometrico dei linfociti CD4 nei pazienti HIV+: l’esperienza multidisciplinare in un laboratorio di Area Vasta. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine. 13(1). 24–28.

4.

Fiore, Pietro, Chiara Marchetti, V. Tullo, et al.. (2015). Electromyography data in chronic migraine patients by using neurostimulation with the Cefaly® device. Neurological Sciences. 36(S1). 115–119. 8 indexed citations

5.

Girardi, Enrico, Paola Scognamiglio, Claudio Angeletti, et al.. (2012). Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis. BMC Health Services Research. 12(1). 38–38. 1 indexed citations

6.

Arlotti, M., Paolo Grossi, Federico Pea, et al.. (2010). Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses. International Journal of Infectious Diseases. 14. S79–S92. 88 indexed citations

7.

Monforte, Antonella d’Arminio, Alessandro Cozzi‐Lepri, Antonella Castagna, et al.. (2009). Risk of Developing Specific AIDS‐Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis. Clinical Infectious Diseases. 49(4). 612–622. 45 indexed citations

8.

Tinelli, Carmine, et al.. (2008). Factors predicting the time for CD4 T‐cell count to return to nadir in the course of CD4‐guided therapy interruption in chronic HIV infection^*. HIV Medicine. 9(1). 19–26. 2 indexed citations

9.

Cozzi‐Lepri, Alessandro, Andrea De Luca, Andrew Phillips, et al.. (2006). A Comparison between Abacavir and Efavirenz as the Third Drug Used in Combination with a Background Therapy Regimen of 2 Nucleoside Reverse‐Transcriptase Inhibitors in Patients with Initially Suppressed Viral Loads. The Journal of Infectious Diseases. 194(1). 20–28. 5 indexed citations

10.

Jemsek, Joseph G., Eduardo Arathoon, M. Arlotti, et al.. (2005). Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients. Clinical Infectious Diseases. 42(2). 273–280. 92 indexed citations

11.

Murri, Rita, Alessandro Cozzi Lepri, Paola Cicconi, et al.. (2005). Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(1). 23–30. 41 indexed citations

12.

Tinelli, Carmine, et al.. (2005). Safety and factors predicting the duration of first and second treatment interruptions guided by CD4+ cell counts in patients with chronic HIV infection. Journal of Antimicrobial Chemotherapy. 57(3). 520–526. 6 indexed citations

13.

Tinelli, Carmine, et al.. (2004). CD4+ cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy.. PubMed. 18(18). 2381–9. 33 indexed citations

14.

Murri, Rita, Alessandro Cozzi Lepri, Andrew Phillips, et al.. (2003). Access to Antiretroviral Treatment, Incidence of Sustained Therapy Interruptions, and Risk of Clinical Events According to Sex. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(2). 184–190. 34 indexed citations

15.

Rezza, Giovanni, Alessandro Cozzi Lepri, Antonella d’Arminio Monforte, et al.. (2000). Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(1). 56–62. 24 indexed citations

16.

Rezza, Giovanni, Alessandro Cozzi Lepri, Antonella d’Arminio Monforte, et al.. (2000). Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(1). 56–62. 34 indexed citations

17.

Monforte, Antonella d’Arminio, Massimo Musicco, Massimo Galli, et al.. (1997). Italian multicentre study of didanosine compassionate use in advanced HIV infection. European Journal of Clinical Microbiology & Infectious Diseases. 16(2). 135–142. 6 indexed citations

18.

Boschini, Antonio, C. Smacchia, Paolo Ballarini, et al.. (1996). Community-Acquired Pneumonia in a Cohort of Former Injection Drug Users With and Without Human Immunodeficiency Virus Infection: Incidence, Etiologies, and Clinical Aspects. Clinical Infectious Diseases. 23(1). 107–113. 83 indexed citations

19.

Arlotti, M., G. Magnani, Renato Maserati, et al.. (1996). Rhodococcus equi Infection in HIV-positive Subjects: A Retrospective Analysis of 24 Cases. Scandinavian Journal of Infectious Diseases. 28(5). 463–467. 56 indexed citations

20.

Aloisi, Francesca, et al.. (1990). Non-invasive antiarrhythmic and hemodynamic assessment of intravenous and oral pentisomide (CM 7857). 6. 421–426.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact